100 Followers on Owler

Cerevel Therapeutics

Read more
Anthony N. Coles's photo - President & CEO of Cerevel Therapeutics

President & CEO

Anthony N. Coles

CEO Approval Rating

90/100

Founded

2018

Status

PublicMerger Pending with Arya Sciences Acquisition Corp IINASDAQCERE

Social Links

Annual Revenue
$ < 1M
Employees
3
Funding
$440M

Cerevel Therapeutics Competitors and Alternatives

1
2
3
4
5
6
7
8
9
10
See more competitor data

Cerevel Therapeutics Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$ < 1M

Cerevel Therapeutics's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 12.3B. Over the last three quarters, Cerevel Therapeutics's revenue has decreased by 88.1%. Specifically, in Q2 2021's revenue was $ < 1M; in Q1 2021, it was $ < 1M; in Q3 2020, it was $ < 1M.

Cerevel Therapeutics News

Cerevel Therapeutics Press Releases

Cerevel Therapeutics Headquarters

222 Jacobs Street Suite 200

Cambridge, Massachusetts02141

844-304-2048

Driving Directions »

Cerevel Therapeutics Summary

ABOUT

Overview

Cerevel is a Massachusetts based biotechnology company that develops and commercializes investigational therapies for the treatment of neuroscience diseases. Cerevel Therapeutics was founded in 2018. Cerevel Therapeutics' headquarters is located in Ca...

CEO

Cerevel Therapeutics's President & CEO, Anthony N. Coles, currently has an approval rating of 90%. Cerevel Therapeutics's primary competitors are Neurocrine Biosciences, Otsuka & Johnson & Johnson.

Acquisitions

There have been no acquisitions found related to Cerevel Therapeutics

Investments

Recent investment data cannot be found related to Cerevel Therapeutics

Frequently Asked Questions about Cerevel Therapeutics

  1. When was Cerevel Therapeutics founded?

    Cerevel Therapeutics was founded in 2018
  2. Who is Cerevel Therapeutics's CEO?

    Cerevel Therapeutics's CEO is Anthony N. Coles
  3. How much revenue does Cerevel Therapeutics generate?

    Cerevel Therapeutics generates $ < 1M in revenue
  4. How much funding does Cerevel Therapeutics have?

    Cerevel Therapeutics has historically raised $440M in funding
  1. Where is Cerevel Therapeutics's headquarters?

    Cerevel Therapeutics's headquarters is in Cambridge Massachusetts, USA
  2. How many employees does Cerevel Therapeutics have?

    Cerevel Therapeutics has 3 employees
  3. What sector does Cerevel Therapeutics operate in?

    Cerevel Therapeutics is in Pharmaceuticals
  4. Who are Cerevel Therapeutics's competitors?

    Cerevel Therapeutics's top competitors are Neurocrine Biosciences, Otsuka , Johnson & Johnson

Trending Companies